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Abstract The effort to understand the mechanism of uncoupling
by UCP has devolved into two models ^ the fatty acid
protonophore model and the proton buffering model. Evidence
for each hypothesis is summarized and evaluated. We also
evaluate the obligatory requirement for fatty acids in UCP1-
mediated uncoupling and the question of fatty acid affinity for
UCP1. The structural bases of UCP transport function and
nucleotide inhibition are discussed in light of recent mutagenesis
studies and in relationship to the sequences of newly discovered
UCPs.
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1. Introduction
Uncoupling protein (UCP1) catalyzes electrophoretic pro-
ton back-£ux across the inner membrane of BAT mitochon-
dria, dissipating redox energy and providing heat to mam-
mals. Knowledge of the mechanism by which UCP1
catalyzes proton conductance has achieved new importance
with the discovery of new and rather ubiquitous mammalian
uncoupling proteins, UCP2 and UCP3, whose transport func-
tions have so far been inferred only by virtue of their strong
sequence identities with UCP1 [1^4]. However, the mechanism
of H transport by UCP1 has remained controversial, and
this disagreement inevitably raises a barrier to progress in
understanding the function of all UCPs. This review will
therefore focus on the biophysical basis of UCP1-mediated
uncoupling.
2. The fatty acid protonophore mechanism of UCP-mediated
H+ £ux
The FA protonophore model, diagrammed in Fig. 1, was
introduced by Skulachev [5] and Garlid et al. [6]. Subsequent
reports have appeared both in support of the model [7^11]
and in opposition to the model [12,13]. As shown in Fig. 1,
UCP catalyzes £ip-£op of the anionic head group of FA from
the matrix lea£et to the outer lea£et of the inner membrane.
Transport of the anion is driven by the high, inside-negative
membrane potential (v8). After the carboxyl head group has
crossed the membrane, it picks up a proton, and the proton-
ated FA spontaneously and rapidly £ip-£ops back to the ma-
trix side, where deprotonation completes the cycle. The net
result of the cycle is delivery of protons with charge to the
matrix. Thus, FA behave as cycling protonophores by virtue
of the fact that UCP permits the anionic charge to move
across the inner membrane.
A striking feature of this model is that UCP1 does not
conduct protons at all. In the FA protonophore model,
UCP transports anions, and proton £ux occurs independently,
by non-ionic di¡usion. The physiological substrates of UCP1
are FA, but a wide variety of anions are transported [14] and
are hypothesized to share parts of the same pathway used by
FA anions, as will be discussed later.
The FA protonophore hypothesis arose from the discovery
that alkylsulfonates are transported by UCP1 and that both
the Vmax and the apparent a⁄nity (1/Km) increase with in-
creasing alkyl chain length [14]. This of course was a major
clue, because alkylsulfonates and FA are identical, except for
their head groups.
The strongest evidence for the hypothesis was provided by a
comparison of two close analogues: laurate and undecanesul-
fonate. Undecanesulfonate anion is transported by UCP1
with Km very similar to the Km for laurate-induced H trans-
port. Undecanesulfonate is also a competitive inhibitor of
laurate-induced H transport, and both anions are competi-
tive inhibitors of Cl3 transport. These analogues di¡er in two
important respects: undecanesulfonate does not catalyze
UCP-mediated H transport and cannot support non-ionic
di¡usion across the bilayer. The latter property is due to the
fact that sulfonates are very strong acids. From these facts, we
deduced that undecanesulfonate transport re£ects a half-cycle
of the physiological transport mechanism. Inasmuch as the
anionic head group of undecanesulfonate, which resembles
laurate in its kinetic properties, is transported by UCP1, there
is no physicochemical basis for excluding the FA anionic head
group from this pathway.
We devoted considerable e¡ort to experiments designed to
falsify the hypothesis by identifying a FA (or analogue) that
induced UCP-mediated H transport but could not deliver
protons by non-ionic di¡usion. An extensive study turned
up no such exceptions [10,11]. Moreover, absence of proton-
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ated FA £ip-£op was found to correlate with inability to
support UCP1-mediated H transport.
3. The fatty acid bu¡ering mechanism of UCP-mediated
H+ £ux
Protons are directly transported by UCP in the bu¡ering
model of uncoupling, introduced by Winkler and Klingenberg
[15]. In recognition of the requirement for FA [15,16], it was
postulated that FA are bu¡ering cofactors that operate in
conjunction with resident H-conducting amino acids, such
as histidines [12,15].
The isolated fact that alkylsulfonates are competitive inhib-
itors of FA-induced H transport via UCP1 [6,16] is consis-
tent with this model, because alkylsulfonates are strong acids
and cannot bu¡er. On the other hand, the fact that the
anionic charge on alkylsulfonates is transported across the
membrane is a serious problem for the bu¡ering model. As
stated above, there is no known physicochemical mechanism
that would permit alkylsulfonate anion transport and prohibit
fatty acid anion transport.
In an important study, Klingenberg and coworkers [12]
have recently shown that mutation of two histidine residues
in UCP1 cause loss of H transport. The authors’ interpreta-
tion of this result is that His145 and His147 comprise part of
the proton-conducting pathway, and they have extrapolated
their ¢ndings to the new UCPs: because UCP2 contains nei-
ther histidine, they conclude that it does not conduct H ions.
Because UCP3 contains only one histidine, they conclude that
it must conduct protons only weakly. It should be pointed
out, however, that plant uncoupling protein (PUMP) cata-
lyzes FA-dependent H £ux [9] and contains no histidines
in this region (see Table 2). Moreover, preliminary evidence
from our laboratories shows that UCP2 and UCP3 also cata-
lyze Fa-dependent H £ux (Garlid, K.D., Jabuîrek, M. and
Jezíek, P., unpublished results).
4. Are fatty acids required for UCP activity?
On the basis of experiments in BAT mitochondria and li-
posomes, the laboratories of Klingenberg [12,15] and Garlid
[6,16] agree that FA are obligatory for UCP1 activity. This
requirement has been called into question in a recent paper
showing that a residual, GDP-sensitive uncoupling remains in
the presence of BSA, leading the authors to conclude that
UCP1 can conduct protons in the absence of FA [13]. It
must be stressed that the BSA-insensitive rate is only about
10^15% of the Vmax in the presence of palmitate. This small
degree of uncoupling is incompetent to achieve the physiolog-
ical role of UCP1, so the relevance of the e¡ect is not clear. It
is also not clear that the e¡ect is outside the range of measure-
ment error2.
As commonly prepared, BAT mitochondria also remain
partially uncoupled in the absence of nucleotides and the
presence of BSA [17]. This ¢nding also led to the conclusion
that mitochondria are uncoupled in the absence of fatty acids.
We carried out a series of experiments that raise doubts about
this interpretation. When prepared in the usual way, BAT
mitochondria exhibited a high GDP-sensitive rate of uncou-
pling that could not be reversed by BSA, even by lengthy
incubations with high BSA concentrations. On the other
hand, when BSA (2^5 mg/ml) was added to the BAT tissue
during homogenization, and maintained in the wash medium
during isolation, uncoupling was reduced to undetectable lev-
els [16]. This hysteresis in the BSA e¡ect emphasizes the fact
that BSA cannot remove all endogenous FA once they are
bound to mitochondria. We believe that three factors contrib-
ute to BSA hysteresis: (i) when present during tissue homog-
enization and release of FA from stores, BSA can e⁄ciently
adsorb FA; (ii) if BSA is not present at this time, mitochon-
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Fig. 1. The UCP-catalyzed protonophoretic cycle. The diagram
shows an inner membrane segment containing UCP1. The complete
uncoupling cycle consists of six steps: (i) FA anion partitions in the
lipid bilayer with its head group at the level of the acyl glycerol
linkages and below the surface of the phospholipid head groups.
This location is shielded from the aqueous, which causes the pKa
values of FA in membranes to be 3^4 units higher than their values
in solution [19]. There is no signi¢cant £ux of FA anion, because
the bilayer energy barrier is too high [30]. (ii) The FA anion di¡uses
laterally in the bilayer to reach a subsurface binding site on UCP
that is shielded from the bulk aqueous phase [14]. (iii) The energy
barrier to FA anion transport is lowered by a weak binding site lo-
cated about halfway through the UCP transport pathway [20]. The
electric ¢eld created by redox-linked proton ejection drives the
anionic head group to the energy well. The preference of UCP for
hydrophobic anions [14] indicates that the hydrophobic FA tail re-
mains in the bilayer during transport. (iv) The FA carboxylate
group moves to the other side of the membrane by a £ip-£op mech-
anism [31], then di¡uses laterally away from the conductance path-
way. (v) The FA is protonated and the protonated FA rapidly £ip-
£ops again, delivering protons electroneutrally to the mitochondrial
matrix and completing the cycle. (Reproduced with permission from
[6].)
Table 1
Km values for fatty acid-dependent, UCP-mediated proton £ux
Fatty acid Kp [reference] Km (Total) Km (Memb) Km (Aqueous)
Lauric 5U103 [32] 8 WM 11.4 mM 2.3 WM
Oleic 3.6U105 [18] 5 mM 9.9 mM 28 nM
Palmitic 3.7U105 [18] 5.3 WM 10.5 mM 28 nM
Km (Total) values refer to total FA in the assay, and were determined as in [5]. Km (Memb) and Km (Aqueous) were determined according to Eqs. 1
and 2, in the text.
2 It is impossible to evaluate whether the BSA-insensitive rates are
statistically di¡erent from zero. No state 4 respiration rates whatso-
ever are provided in the paper, nor are statistics provided. Instead, the
e¡ects of BSA are compared on the basis of respiratory control ratios
from two di¡erent populations of mitochondria.
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dria become abnormally exposed to FA that bind with high
a⁄nity to mitochondria (partition coe⁄cients surpass 105,
even for those FA that are readily removed by BSA [18]) ;
(iii) once FA have been allowed to partition into the inner
membrane they will be more di⁄cult to remove ^ they must
leave the inner membrane, cross the intermembrane space to
reach the outer membrane, and then leave the outer mem-
brane to bind to BSA. Taking these factors into account,
together with the experimental phenomenon of hysteresis,
we are skeptical of claims [13,17] that brief exposure to
BSA in the assay medium is equivalent to complete FA re-
moval.
The obligatory requirement of UCP1 for FA is most appa-
rent in reconstitution experiments, in which BioBeads are em-
ployed to remove detergent and form liposomes [6,15]. When
frozen BAT mitochondria were used, we invariably observed a
residual H £ux in proteoliposomes. This e¡ect was elimi-
nated by washing the thawed mitochondria with 5 mg/ml
BSA prior to extraction [6]. When fresh BAT mitochondria
were used, BioBeads alone apparently removed all of the en-
dogenous FA, because residual proton £ux was nearly identi-
cal to proton leak in protein-free liposomes [5]. From these
experiments, and those of Winkler and Klingenberg [15], it is
clear that UCP1-mediated H £ux exhibits an absolute re-
quirement for FA in the reconstitution system.
5. The apparent Km for fatty acid-induced uncoupling by UCP1
In the protonophore model, FA di¡use laterally within the
membrane until they reach a weak binding site on UCP that
serves to concentrate the FA in the conductance pathway [5].
It is evident that FA interaction with UCP takes place in the
lipid phase. We reported Km values based on total FA,
[FA]Tot. These can readily be converted to Km values based
on membrane FA, [FA]Memb through recently available parti-
tion coe⁄cients in liposomes [18] :
FAMemb 
KpFATot
1 KpWVm=Vag
 1
where Kp is the partition coe⁄cient and Vm/Va is the lip-
id:aqueous volume ratio, taken to be 0.5U1033 in these ex-
periments (0.5 mg lipid/ml). The corresponding aqueous con-
centration, [FA]Aq, is given by
FAAq  FAMemb=Kp 2
Table 1 contains Km data for three FA studied in liposomes
containing reconstituted UCP1. The aqueous Km values vary
by a factor of 103, whereas membrane Km values are remark-
ably similar at 10^11 mM, consistent with a common binding
site on UCP1.
A recent paper [13] contains a confused discussion of the
apparent a⁄nity of UCP1 for palmitate. The authors com-
pared aqueous Km values with total Km values, despite an
explicit statement that the latter values include the partition
coe⁄cients [5]. The erroneous conclusion that one set of val-
ues is more ‘physiological’ than the other [13] arises entirely
from this inappropriate comparison. When properly com-
pared, the observed Km values for FA are very similar in all
published experiments. Thus, the Km for palmitate is about 15
nmol/mg protein (80 nM free FA) in intact mitochondria [13],
and about 10 nmol/mg lipid (21 nM free FA) in proteolipo-
somes (Table 1).
6. Is UCP1 a FA channel or carrier?
A minimum model of anion transport through UCP1 will
include binding sites on both surfaces and a central binding
site to facilitate transport through the bilayer. In fact, the
‘surface’ binding sites are shielded from the aqueous medium
and are therefore subsurface, as is evident from the fact that
transport of alkylsulfonates is completely una¡ected by hy-
drophilic sulfonates [14]. The remarkable observation that
any competitive inhibitor of FA or alkylsulfonate transport
is also transported by UCP1 [14] also indicates that the bind-
ing sites are subsurface. They are probably located near the
phospholipid acylglycerol linkages, which is also the equili-
brium position of the FA carboxylic moiety [19].
The existence of a single energy well located near the center
of the membrane was deduced from £ux-voltage analysis of
non-ohmic Cl3 £ux [20]. The FA protonophore model states
that Cl3 cannot access the subsurface binding sites for FA,
and that Cl3 is transported by virtue of thermal bombard-
ment of the membrane. Thus, Cl3 uses only part of the phys-
iological conductance pathway for FA anions [6]. ‘Random’
access to the central energy well in UCP1 is re£ected in the
very low a⁄nity for Cl3 (Kmv140 mM) [6].
The fact that Vmax values for alkylsulfonates increase with
increasing chain length [14] places a further constraint on the
transport pathway ^ the hydrophobic tail of FA must remain
at all times in contact with the lipid bilayer core and must
turn and reverse direction within this environment as the FA
head group moves from one side to the other.
Within these constraints, the transport pathway in UCP1
may be an anion carrier/gated pore [21] or a hydrophobic,
single-¢le, anion conductance pathway [20]. These alternatives
cannot be distinguished at the present time. In either case,
polar or cationic residues should reside in the subsurface re-
gion to serve as initial binding sites for the FA head group.
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Table 2
Comparison of amino acid sequences among the uncoupling proteins
135 140 145 150 155 160
UCP1 134 E V V K V R L Q A Q S H L H G I ^ ^ K P R Y T G T Y N A Y R I
UCP2 138 D V V K V R F Q A Q A R A G G G ^ ^ R Y R Q S ^ T V N A Y K T
UCP3 138 D V V K V R F Q A S I H L G P S R S D R K Y S G T M D A Y R T
PUMP 140 D L V K V R L Q A E G K L P A G V P R ^ R Y S G A L N A Y S T
The sequences given are found in the matrix loop segment between the third and fourth transmembrane helices. The sequences for UCP1, UCP2,
UCP3, and PUMP are from [34], [2], [3], and [33], respectively. PUMP has been analyzed by MALDI-mass spectroscopy (Jezek et al., unpublished
data) and more than 30% of its sequence was found identical to the StUCP gene cloned from potato gene library [33]. The matched sequences
included the matrix loop segment, con¢rming that FA-translocating PUMP contains no histidines in this region.
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Movement across the membrane would be facilitated by addi-
tional polar or cationic groups that are buried near the center
of the membrane.
7. Location of the fatty acid transport pathway in UCPs
Mutations of the seven cysteines in UCP1 to serine had no
e¡ect on function or regulation of UCP1 [22,23]; however,
Gonzalez-Barroso et al. [24] found that mutation of Cys304
to glycine increased the apparent a⁄nity of UCP1 for palmi-
tate about 2-fold [13]. A 2-fold change in a⁄nity re£ects a
very small change in binding energy, about 0.38 kcal/mol.
This is most likely a consequence of minor conformational
changes in the mutated protein and not due to involvement
of Cys304 in or near the transport site.
In contrast, mutation of histidines 145 and 147 had a dra-
matic e¡ect [12]. Single mutations reduced laurate-induced H
£ux by 85^90%, and the double mutation nearly abolished H
transport. Loss of function after mutation can be di⁄cult to
interpret; however, a very nice aspect of this work was the
demonstration that Cl3 transport and nucleotide binding were
una¡ected by the amino acid substitutions. The mutations
were thus speci¢c for H transport (alkylsulfonate transport
was not evaluated).
These ¢ndings, which strongly imply that H145 and H147
are located in the FA anion translocation pathway, are fully
consistent with the FA protonophore model. In view of the
preceding discussion, the fact that His mutations block FA
transport without a¡ecting Cl3 transport implies that these
residues reside near the subsurface binding site for FA at
the matrix lipid-water interface. We would predict further
that one or both of these histidines protrudes partially into
the membrane to be near the level of the acylglycerol linkages.
H145 and H147 are located in the matrix loop between
transmembrane helices 3 and 4 of UCP1. As shown in Table
2, each of the UCPs contain 3^4 positive charges in the stretch
corresponding to H145 and R152 in UCP1. These cationic
residues may provide subsurface binding sites for hydrophobic
anions and may also serve to anchor this segment to the
membrane phospholipid head groups. To provide internal
anion binding sites, the loop must protrude to a considerable
extent into the membrane. In fact, this is in accord with the
folding model of Klingenberg and Nelson [25] in which a L-
loop is inserted between each pair of transmembrane helices.
The eight downstream residues between R152 and R161 in
UCP1 are rich in hydrogen-bonding side chains (see Table
2), and these residues could form the central energy well of
the anion conductance pathway.
Unlike the bu¡ering model, which requires dissociable res-
idues for H transport [12], the FA protonophore model
merely requires weak binding sites for anions, which may be
provided by histidine, lysine, or arginine. Similarly, the energy
well sites may be provided by residues that are cations or H-
bond donors. The sequences in Table 2 show that all UCPs
contain such sites.
Additional experiments with the His mutants may help to
distinguish between the two UCP transport models. The bu¡-
ering model envisions a separate anion transport pathway in
UCP1, and hence predicts that alkylsulfonate transport would
be una¡ected by the mutations. In the FA protonophore
model, transport of Cl3 and short-chain sulfonates would
be una¡ected, because they do not use the surface binding
sites. On the other hand, transport of long-chain sulfonates
would be abolished by the His mutations, like FA. More
precisely, the model predicts that the mutations would in-
crease the Km to levels exceeding the solubility of both long-
chain FA and sulfonates.
8. Regulation of UCP1
There is considerable agreement about the nature of nucleo-
tide regulation of UCP1. Purine nucleotide (PN) inhibition of
UCP-mediated H £ux is purely allosteric, as con¢rmed by
non-competitive kinetics, by the lack of FA in£uence on the
Ki for PN inhibition [16], and by EPR studies with 5-doxyl-
stearic acid [26]. These studies show that FA anion transport
and nucleotide inhibition are distinct features of UCP involv-
ing two distinct binding domains.
The nucleotide binding pocket in UCP1 has been mapped
by photoa⁄nity labelling and site-directed mutagenesis, and is
very extensive. Nucleoside phosphates interact with the three
arginines that are located on helices 2, 4, and 6 [27], and the
sugar base reacts with the matrix segment D233-E261 that
connects helices 5 and 6. The latter interaction is presumed
to confer nucleotide speci¢city [28].
Nucleotide binding and inhibition take place in three steps
[27]. First, binding of the sugar base moiety and the binding
of one L-phosphate group result in a loose-binding conforma-
tion of UCP1. In the second step, protonation of E190 makes
R83 available for binding to the second charge on the L-phos-
phate of diphosphates and the Q-phosphate of triphosphates.
An unidenti¢ed histidine is thought to bind to the second
charge on the Q-phosphate of triphosphates [28]. These events,
which cause tight binding of PNs [29], have been shown to be
insu⁄cient for inhibition [27]. To reach the inhibited state, K-
phosphate must bind to R276. This ¢nal step induces a con-
formational change that modi¢es the anion transport path-
way, causing inhibition of transport [27].
It is noteworthy that the three phosphate binding arginines
are conserved in UCP2, UCP3, and PUMP, suggesting that
these proteins are also regulated by nucleotides. On the other
hand, there are strong di¡erences in the nucleotide-binding
matrix loop between the ¢fth and sixth transmembrane do-
mains, suggesting that nucleotide speci¢cities may di¡er.
9. Summary
Two competing hypotheses describe the mechanism of un-
coupling by UCP ^ the FA protonophore model and the H
bu¡ering model. Both models employ the experimental obser-
vation that FA are obligatory for UCP1-mediated uncou-
pling. It may be possible to discriminate between the models
when the transport functions of UCP1 and UCP2 are known.
The FA protonophore model predicts that they will catalyze
FA-dependent proton £ux, whereas the bu¡ering model pre-
dicts that they will not.
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